AMY NUGENT: Open Payments
NPI 1245299288 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,699 in 106 payments from 15 companies in 2025. Trend: 2023 $2,848 · 2024 $2,120 · 2025 $1,699
Food & beverage: $1,699
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 63 | $830 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $266 |
| Gilead Sciences, Inc. | 6 | $120 |
| Janssen Biotech, Inc. | 4 | $76 |
| Ardelyx, Inc. | 3 | $60 |
| QOL Medical, LLC | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Lilly USA, LLC | 2 | $40 |
| VIVUS LLC | 2 | $33 |
Products named: RINVOQ, CREON, ENTYVIO, LINZESS, MAVYRET, SKYRIZI, TREMFYA, IBSRELA.
Industry payments across IN — which companies pay providers there.
